Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2022-03-17 00:00:00 ET · period of report 2022-03-15 · accession 0001567619-22-007179 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-17 | 2022-03-15 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | A - Grant | $0.00 | +40.3K | 378.8K | +12% | $0 |
| DM | 2022-03-17 | 2022-03-15+ | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | F - Tax | $78.58 | -43.9K | 340.5K | -11% | -$3.45M |
| D | 2022-03-17 | 2022-03-15 | BMRN | BIENAIME JEAN JACQUES | CEO, Dir | A - Grant | $0.00 | +58.0K | 58.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-15 | A | A | 40,280 | $0.00 | 378,849 | D | — | — | (F1) Restricted stock units granted on March 15, 2022. Price not applicable. |
| 2 | Common | Common Stock | 2022-03-16 | F | D | 5,560 | $80.72 | 334,983 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-15 | F | D | 38,306 | $78.27 | 340,543 | D | — | — | |
| 4 | Derivative | Stock Option (Right to buy Common Stock) | 2022-03-15 | A | A | 58,040 | $0.00 | 58,040 | D | $78.27 · 2023-03-15 to 2032-03-14 | 58,040 Common Stock | (F2) Option grant vests 12/36th on March 15, 2023 and 1/36th on the 15th day of each month thereafter. |